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Abstract: The increased prevalence of diabetes in Middle Eastern countries is a health policy 
priority. Important risk factors for diabetes have been identified. Lifestyle interventions and 
adherence to medications are central to disease prevention and management. This review 
focuses on the management of type 2 diabetes mellitus in Middle Eastern countries. The aim is 
to identify the ways in which knowledge, health beliefs, and social and cultural factors influence 
adherence to medication and lifestyle measures. Thirty-four studies were identified following 
a systematic search of the literature. The studies describe the influence of knowledge, health 
beliefs, culture, and lifestyle on the management of type 2 diabetes mellitus in the Middle 
East. Findings indicate a lack of health knowledge about diabetes among populations, which 
has implications for health behaviors, medication adherence, and treatment outcomes. Many 
identified health beliefs and cultural lifestyle factors, such as religious beliefs, beliefs about 
fasting during Ramadan, and sedentary lifestyles played a role in patients’ decisions. For better 
management of this disease, a collaborative approach between patients, their families, health 
care professionals, and governments should be adopted. Implementing behavioral strategies and 
psychological interventions that incorporate all health care professionals in the management 
process have been shown to be effective methods. Such services help patients change their 
behavior. However, the utilization of such services and interventions is still limited in Arabian 
countries. Physicians in the Middle East are the health care professionals most involved in the 
care process.
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Introduction
Diabetes mellitus (DM) is a leading cause of death in industrialized and developing 
countries. In the Middle East, DM is a rapidly growing chronic disease. Saudi Arabia, 
Kuwait, Qatar, and Egypt are among the ten countries in the world with the highest 
prevalence of DM. Major contributory factors for type 2 diabetes mellitus (T2DM), 
which is most prevalent in Middle Eastern countries, include low activity levels, poor 
diet, and excess body weight.1 Lack of health awareness, health beliefs, attitudes, and 
lifestyle are all contributing to the rising prevalence of obesity and DM in the Middle 
East.2 In particular, lack of awareness about nutritional information and the significance 
of healthy eating have led to adoption of a poor diet.3,4 Social and economic changes 
are also important. These include changing lifestyles in terms of urbanization and 
changing dietary habits. Increased wealth resulting from oil production has enabled 
widespread car ownership. As a consequence, there is decreased physical activity 
along with rising levels of obesity and smoking.5–9
Many people in the Middle East have been found not to appreciate the potential 
seriousness of diabetes, its complications, or early detection signs.10 Patients’ beliefs 
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influence their uptake of lifestyle measures and their use 
of medicines. Adherence refers to “the extent to which a 
person’s behavior: taking medication, eating a suitable diet, 
and/or executing lifestyle changes correspond with agreed 
recommendations from a healthcare provider”.11 Adherence 
was found to be low among Middle Eastern populations. 
In particular, studies have estimated medication nonadher-
ence rates for diabetes to be 68% or lower.12–14 The main 
reasons for patients’ nonadherence were forgetfulness, 
confusion about the required duration for using medica-
tion, and disbelief about the overall effectiveness of the 
medication.15
The aim of this review is to identify ways in which 
knowledge, health beliefs, and culture influence adherence 
to medication and lifestyle measures for T2DM patients 
in Middle Eastern countries. In addition, this review 
aims to outline all the determinants of patients’ behavior 
to assist researchers to further investigate further the 
issues identified or to identify new ones. In addition, this 
review will assist in identifying policy implications and 
propose recommendations to enhance the management 
of this disease in the region and subsequently improve 
health outcomes.
Methods
Search terms and search strategy
A systematic search of studies relating to medicines use 
and medication adherence in diabetes in the Middle East 
was performed using the following databases: EMBASE, 
PubMed, Web of Science, and Index Medicus for the Eastern 
Mediterranean Region; the search was selected for the period 
from 1990 to 2015. The search terms were (diabetes AND 
adherence or compliance AND medicine use AND Middle 
East OR Kuwait OR United Arab Emirates OR Saudi Arabia 
OR Bahrain OR Qatar OR Oman OR Jordan OR Egypt OR 
Lebanon OR Syria OR Iraq OR Iran OR Palestine OR Israel 
OR Turkey OR Libya), with or without the combination of 
the search terms (health beliefs, lifestyle, patient behavior, 
insulin). Studies that discussed medicine use during the holy 
month of Ramadan were searched using the search terms 
(Ramadan fasting AND diabetes mellitus). In addition, the 
Google search engine was used to identify clinical journals 
in Middle Eastern areas. These journals were searched for 
relevant papers, and the bibliographies of relevant papers 
were hand searched for further articles. In addition, an expert 
in diabetes in the area was contacted to help in identifying 
relevant articles.
inclusion or exclusion criteria
The electronic database search yielded 834 studies, and 
further studies were identified from other sources, such 
as contact with an expert (n=1), searching reference list 
(n=3), and using Google search engine (n=10). Removing 
duplicates resulted in a total of 822 studies. Titles and 
abstracts were evaluated to determine eligibility for full 
screening. Studies that employed acceptable quantitative 
and/or qualitative methods, including randomized controlled 
trials, observational studies (eg, cross-sectional, experimen-
tal, and interventional), and review articles were included. 
All studies wherein adherence to medicines and/or other 
management behaviors and/or lifestyle measures among 
adults with diabetes in Middle Eastern countries were 
explored were eligible for inclusion. In addition, studies 
that focused on prevention and/or management of the 
condition in the region and associated factors were eligible. 
The inclusion criteria required that the study population 
be adults (18 years and older) with diabetes and from a 
Middle Eastern country. Studies that involved all sexes 
and ethnicities, urban and rural, residents and expatriates, 
and all socioeconomic and educational backgrounds were 
included. In addition, the review included studies at differ-
ent health care levels. Overall, 34 studies were classified 
as appropriate for full review. Eight studies were excluded 
due to unavailability of full access to the study (n=3), the 
quality of the study (n=3), or due to inclusion of irrelevant 
subjects, eg, pregnant women, who have distinct needs 
(n=2). The summary of the literature search procedure is 
illustrated in Figure 1.
Data extraction or quality assessment 
processes
Once all relevant studies had been identified, full-text 
manuscripts were retrieved in hard copy for assessment. 
Information was extracted into a pro forma that included 
primary author’s name, date of publication, setting, country 
of study, number of participants, study design and the 
main study findings regarding the possible determinants 
of medicine-taking behavior among patients with DM 
in the Middle East, and sociocultural factors relevant to 
the prevalence and management of T2DM in the region 
(Table 1). This enabled identification of papers that addressed 
specific topics and issues relevant to the study objectives, 
and facilitated the retrieval of information.
The quality of each study was assessed using checklists 
adapted from the Critical Appraisal Skills Program. 
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The authors of this article undertook all stages of identification, 
review of papers, and analysis. Any disagreements were 
resolved through regular meetings and discussions.
Results
A total of 34 studies were identified from all regions of the 
Middle East: Kuwait (two studies), Iran (three), Saudi Arabia 
(five), Turkey (one), Palestine (two), Israel (three), Jordan 
(one), Oman (five), Libyan Arab Jamahiriya (one), Egypt 
(two), and United Arab Emirates (four). Three studies were 
across Middle Eastern countries, and one study focused on 
the Gulf Cooperation Council countries.
Of these 34 studies, 13 discussed issues related to 
T1DM and T2DM,3,4,7,12–14,16–21,43 while 14 focused on T2DM 
only.22–34,36 Six of the studies addressed other long-term 
diseases alongside diabetes,15,35,37–40 and one focused on 
lifestyle issues and obesity.6 All the studies were conducted 
among adult populations ($18 years of age). The settings 
of the research studies were primary health care centers 
(n=8), hospitals (n=4), diabetes centers/clinics (n=10), a 
retirement club (n=1), household (n=1) and a school health 
clinic (n=1). Settings of some studies (n=5), other than the 
reviews (n=5), were not stated (n=1). The sample sizes of 
the reviewed studies ranged from 91 to 41,936 participants 
for the quantitative studies and from 9 to 75 participants for 
the qualitative studies (Table 1).
Most studies (n=24) employed survey methods to collect 
data and applied quantitative analytical procedures to explore 
the determinants of patients’ medicine-taking behavior, such as 
health awareness and beliefs. Only four studies applied quali-
tative methods (focus groups and interviews).26,27,31,36 These 
studies investigated factors that affected patients’ management 
behaviors from the perspectives of patients themselves (n=2) 
and from the perspectives of health care professionals (n=2). 
One study combined quantitative and qualitative methods 
(questionnaires and interviews).12 All of the studies were 
original articles except five, which were reviews.6,15,28,32,33
Lack of health awareness about diabetes 
and its management
Knowledge is a prerequisite of preventive health behavior 
and may motivate patients to take actions for treating their 
Figure 1 Summary of literature search procedure for this review.
Abbreviation: T1DM, type 1 diabetes mellitus.
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Table 1 Studies of determinants of adherence to treatment and self-management behavior among patients with DM in Middle eastern 
countries
Study/setting/location Sample Methods/measures Study findings and conclusions
Al-Kaabi et al,3 diabetes  
outpatient clinics,
United Arab emirates
409 patients with DM Cross-sectional study.
Dietary practices and risk profile 
measured by an interviewer-
administered questionnaire.
24% of patients read food labeling, 76% 
reported being unable to distinguish between 
high and low carbohydrate index food items and 
no one reported counting calorie intake, 46% 
reported never seen by a dietitian since their 
diagnosis.
Abahussain and el-Zubier,4
School Health Clinic, Saudi 
Arabia
91 patients with DM Knowledge of females with 
DM, school teachers about 
the disease, and adherence to 
medications, diet, and exercise 
measured by a structured 
questionnaire.
73% of patients know about the symptoms 
of hypoglycemia, 52.7% of patients complied 
with treatments, 50% followed diet, and 5.5% 
complied with exercise. 25% using herbs for the 
management of diabetes.
Mabry et al,6 GCC, gulf 
cooperation council countries
Not stated Review The physical activity, which is a modifiable risk 
factor for several chronic diseases, of patients in 
the GCC countries is very low.
Salti et al,7 13 eastern  
mediterranean countries
12,243 patients with DM Retrospective transversal 
survey.
Fasting and adherence of 
patients to medications in 
Ramadan.
42.8% of patients with T1DM and 78.7% with 
T2DM fasted for at least 15 days. Less than 50% 
changed their treatment dose (one-fourth treated 
with oral antidiabetic drugs and one-third using 
insulin.
Kamel et al,12  
diabetes clinic, egypt
300 patients with DM Cross-sectional study.
Adherence to medication 
measured by patients’ self-
report using questionnaire.
1.7% of patients had poor, 20% satisfactory, and 
78.3% very good compliance.
Khattab et al,13  
Primary Health Care Center,  
Saudi Arabia
294 patients with DM Cross-sectional study.
Adherence to medications 
measured by self-report 
questionnaire and pill count.
1.4% of patients had poor compliance, 14% fair 
compliance, and 84.2% good compliance.
Roaeid and Kablan,14  
diabetes center,  
Libyan Arab Jamahiriya
805 patients with DM Cross-sectional study.
Adherence to treatment 
measured by patient’s self-
report using interviews and 
questionnaire.
27.1% of patients do not take their treatments 
regularly.
Al-Qasem et al,15 (review) 
middle eastern countries
Patients with chronic 
diseases 
Review Nonadherence to medications among patients 
with chronic diseases in Middle eastern countries 
constitutes a problem.
elliott et al,22 Primary Health 
Care Clinics, Oman
309 patients with T2DM Prospective survey.
Diabetes self-management 
and education assessed by a 
questionnaire.
26% of patients unaware how to recognize or 
respond to hypoglycemia, 49% and 60% do 
not recognize hyperglycemia or respond to it, 
respectively, 62% do not monitor their blood 
glucose levels, one-third of patients using insulin, 
independently adjust dosages.
Al-Saeedi et al,16 Primary Health 
Care Clinics, Saudi Arabia 
1,039 patients with DM Cross-sectional study.
Patterns of treatment-related 
misconceptions measured by 
interviews using a structured 
questionnaire.
39% of patients had a high treatment 
misconception score. 16.5% think that cure from 
diabetes is expected following a short course of 
treatment and 23% think that they could eat as 
long as medications are taken.
Shams and Barakat,23 Specialized 
Medical Hospital, egypt 
226 patients with T2DM Cross-sectional study.
Adherence to treatment and 
other self-care behavior (eg, diet 
and exercise) using a multiple 
choice graded questionnaire. 
Adherence to treatment, diet, and exercise were 
suboptimal. Patients’ knowledge about the disease 
and beliefs about medicines significantly affected 
therapeutic adherence.
Alhewiti,35 Family Medicine 
Clinics, Saudi Arabia
408 patients with chronic 
diseases including diabetes
Cross-sectional study.
Adherence to treatment and 
beliefs about medicines using 
MMAS-8 and BMQ.
51% of participants who had diabetes were low 
adherents. Low adherence was associated with 
negative beliefs about medicines.
(Continued)
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Table 1 (Continued)
Study/setting/location Sample Methods/measures Study findings and conclusions
Sweileh et al,24 Primary Health 
Care Clinic, State of Palestine
405 patients  
with T2DM 
Cross-sectional study.
Adherence to medicines 
using MMAS-8, beliefs about 
medicines using BMQ and 
diabetes-related knowledge 
using MDKT.
42.7% of the participants were nonadherents 
(MMAS-8 score ,6). Nonadherence was 
significantly associated with disease-related 
knowledge, beliefs about necessity of medicines, 
and concerns about adverse consequences of 
medicines.
Aflakseir,25 outpatient clinic, iran 102 patients  
with T2DM
Not stated.
illness perceptions, beliefs about 
medicines, and medication 
adherence measured by iPQ, 
BMQ, and MARS. 
Patients having concerns about negative effects 
of medicines show low levels of adherence to 
medications.
Alhyas et al,26 Diabetes Center, 
United Arab emirates 
9 health care professionals 
providing care to patients 
with T2DM 
Qualitative research.
Barriers to health care 
professionals’ motivation 
measured by semistructured 
interviews with health care 
professionals.
Barriers that affect health care professionals’ 
motivation in providing good quality care are 
heavy workload, lack of patient compliance, 
awareness and cultural beliefs, and attitudes about 
diabetes. 
Al-Saeedi et al,17 Primary Health 
Care Clinics, Saudi Arabia
1,039 patients  
with DM
Not stated. 
Beliefs in traditional herbal 
medicines measured by a 
structured questionnaire.
15.6% of patients believe in the safety and efficacy 
of traditional medicines. 25.8% believe that they 
might be beneficial.
Jeragh-Alhaddad et al,36 Primary 
Health Care Clinics and 
hospitals, Kuwait
20 patients  
with T2DM
Qualitative study.
Assessing adherence to 
medicines and health beliefs 
of patients using face-to-face 
interviews. 
Many factors were found to impact patients’ 
adherence to medicines. These were related to 
health care providers and system, culture, and the 
patients themselves. 
Ali et al,27 Primary Health Care 
Clinics, United Arab emirates 
75 women at  
high risk of T2DM
Qualitative study.
weight management behaviors 
and perceptions of women at 
high risk of T2DM using focused 
group interviews.
Low motivation, lack of social support, competing 
demands, lack of culturally sensitive exercise 
facilities, and sociocultural norms are the main 
barriers cited by participants. 
Hui et al28 Patients with T2DM Review Structured education should be focused to 
patients who wish to fast in Ramadan, for better 
managing their condition while fasting.
Mishali et al,18 Maccabi Health 
Care Services, israel
119 patients with DM Not stated.
Self-efficacy measured by 
questionnaires and resistance to 
treatments measured by RTQ.
Self-efficacy impacts on patients’ adherence to 
their treatments.
Aflakseir,37 Retirement Club, 
iran
178 patients with 
diabetes, coronary heart 
disease, chronic pain, and 
hypertension
Not stated.
illness perceptions and 
medication adherence using iPQ 
and MARS. 
42% of patients reported nonadherence to their 
prescriptions, 58% adhere to their medicines.
illness perceptions such as timeline, perceived 
consequences, and treatment control predicted 
patients’ adherence to their medications. 
Yekta et al,19 Health Care 
Clinics, iran 
400 patients with DM Cross-sectional study.
Factors influencing self-care 
practices measured by a 
questionnaire.
Patients’ self-care practices were good in 15.1%, 
moderate in 58.7%, and poor in 26.2%.
Jamous et al,20 Military Medical 
Services Clinic, Palestine
131 patients with DM Cross-sectional descriptive study. 
Adherence and treatment 
satisfaction using MMAS-8 
and treatment satisfaction 
questionnaire.
38% of patients had high adherence, 58% had 
medium, and 16.9% had low adherence rates.
Jimmy et al,29 household, Oman 158 patients  
with T2DM
Cross-sectional study.
Adherence to medicines  
using questionnaire-based pilot 
survey. 
Adherence to medicines of patients with T2DM 
was good. Forgetfulness was the main factor that 
contributed to nonadherence followed by low 
beliefs about the necessity of taking medicines and 
the perceived side effects.
(Continued)
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Table 1 (Continued)
Study/setting/location Sample Methods/measures Study findings and conclusions
Al Shafaee et al,43 Health Care 
Centres, Oman
563 adults (general 
population)
Not stated knowledge and 
perception of diabetes using a 
questionnaire
Knowledge of diabetes was suboptimal. Only 
47%, 57%, and 55% responded correctly to 
questions on diabetes definition, symptoms, and 
complications respectively. Only 5,21%, and 17% 
identified obesity, physical activity, and family 
history, respectively, as risk factors for diabetes.
ibrahim et al,38 Al-Qassimi 
Hospital, United Arab emirates
240 patients with chronic 
diseases
Cross-sectional study.
Factors affecting patients’ 
compliance to treatments 
measured by a validated 
questionnaire.
Forgetfulness is the main reason for 
nonintentional noncompliance (75%) and 
polypharmacy is the main cause for intentional 
noncompliance (13.3%).
Khattab et al,30 The National 
Centre for Diabetes, 
endocrinology, and Genetics, 
Jordan
917 patients  
with T2DM
Systematic random sample.
Medication adherence, barriers 
to adherence, and attitude 
toward diabetes measured by 
prestructured questionnaires.
65.1% of patients not following eating plan as 
recommended by dietitian, had negative attitude 
toward diabetes, increased barriers to adherence 
scale scores, and poor glycemic control. 
Abdulhadi et al,31 Primary Health 
Care Clinics, Oman
27 patients  
with T2DM
Qualitative research.
Perceptions of patients with 
T2DM regarding quality of care 
provided measured through 
focused group discussions.
Weaknesses identified by patients include health 
education and professional competency of health 
care providers.
Biderman et al,39 Health Care 
Organizations, israel
630 patients with diabetes, 
hypertension, or ischemic 
heart diseases
Systematic random sample from 
computer database.
Diabetes treatment satisfaction 
measured by telephone 
interviews using DTSQ and 
adherence to treatments and 
lifestyle measures.
51.9% reported difficulties in changing their 
dietary habits, 50.3% in changing their physical 
activities, 22.7% in attending follow-up visits, and 
9.8% in taking medications.
Patients taking OHAs were more satisfied than 
those taking OHA and insulin.
Serour et al,40 Family Practice 
Health Centers, Kuwait
334 patients with T2DM, 
hypertension or both
Prospective study.
Adherence and barriers 
of complying with lifestyle 
recommendations measured by 
a structured questionnaire. 
Barriers to adherence to diet: unwillingness, 
difficulty adhering to a diet different than rest of 
family, social gatherings. Barriers to adherence 
to exercise: lack of time, coexisting diseases, and 
adverse weather conditions.
Badran and Laher,32 
arab-speaking countries
Patients with T2DM Review Several socioeconomic, dietary, and lifestyle 
factors are associated with T2DM in Arabic-
speaking countries.
Al-Shookri et al,33 Oman Patients with T2DM Review Lifestyle and behavior of patients with T2DM in 
Oman and other Middle east countries contribute 
to the high prevalence of this disease.
Abdulhadi et al,34 Primary Health 
Care Clinics, Oman
90 consultations 
between doctors and 
nurses involved in the 
management of patients 
with T2DM
Observational study.
Health care providers’ 
interactions with patients 
focusing on consultation 
environment and some aspects 
of care and information 
measured by checklists.
52% of doctors’ consultations were suboptimal.
elis et al,21 Maccabi Health Care 
Services, israel
41,936 patients with DM Cross-sectional study.
Rate of reaching all glycemic, 
lipids, and blood pressure target 
levels among diabetic patients.
13% of patients achieved all three target levels. 
This was significantly associated with compliance 
to treatments and medical visits.
Abbreviations: DM, diabetes mellitus; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; GCC, Gulf Cooperation Council; MMAS-8, 8-item Morisky 
Medication Adherence Scale; BMQ, Beliefs about Medicines Questionnaire; MDKT, Michigan diabetes knowledge test; iPQ, illness Perception Questionnaire; MARS, Medication 
Adherence Report Scale; RTQ, Resistance to Treatment Questionnaire; DTSQ, Diabetes Treatment Satisfaction Questionnaire; OHAs, oral hypoglycemic agents.
diabetes.12,22,41 Patients with T2DM need to understand their 
disease and how to treat it, as they are responsible for their 
daily control behavior.42 Many studies have discussed the 
knowledge of patients with diabetes in the Middle East. 
Poor knowledge and lack of health awareness about the 
proper management of the disease, and its seriousness, were 
reported in all studies. For example, one study reported that 
patients had poor knowledge about the effects of diabetes 
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on the eye and kidney. Also, it has been found that patients 
lack the awareness about the symptoms of hypoglycemia 
and its treatment.14 Another study revealed that a significant 
proportion of people had no information regarding preventive 
measures needed to cope with diabetes.43 One study noted 
that a substantial proportion of patients did not mention 
any signs of abnormal glucose levels, nor knew how to 
detect hypoglycemia.22 Kamel et al,12 in Egypt, found the 
majority of patients had poor knowledge about diabetes, its 
complications, and how to control it. Another study reported 
that patients believed that diabetes would be cured after a 
short course of treatment. In that study, the patients believed 
that they could eat whatever they wanted as long as medicines 
were taken.16
Health awareness and medicines use
In five studies, patients demonstrated better adherence to 
treatment when they received sufficient information about the 
disease and its complications, medicines, and dosage.12,16,23,24,35 
Moreover, patients who believed that diabetes would last a 
long time had better medication adherence.25
Some studies have shown that poor knowledge of dia-
betes and its potential consequences discourages patients 
from adhering to their therapeutic regimens. Such studies 
found that patients may use herbs to control their diabetes 
while abstaining from their conventional treatment.4,17,26–36 
In addition to the use of herbs, poor awareness about how to 
manage the disease led to actions that potentially affected 
glycemic control. For example, Roaeid and Kablan14 reported 
that some patients omitted their evening insulin doses, did not 
store insulin in a refrigerator or did not shake it before use, 
did not routinely change the injection site, and used insulin 
syringes more than once.
A study by Elliott et al22 found that some patients 
were unable to distinguish between hypo- and hypergly-
cemic attacks and consequently were practicing poten-
tially prob lematic actions such as increasing their doses of 
oral antidiabetic medicines or insulin or going to sleep when 
experiencing hypoglycemia and drinking juice or eating sour 
food when having hyperglycemia.
Health awareness and self-care behavior
In patients with diabetes, health awareness is an important 
determinant of health behavior.12 For example, patients’ 
under standing of hypertension as a diabetic complication 
motivated them to have regular blood pressure checks. 
Knowledge about retinopathy and foot ulcers was associ-
ated with patients’ attendance at eye screenings and foot 
checkups.14
Self-monitoring of blood glucose levels and responding 
to hypo- and hyperglycemic episodes are an integral part of 
the management of diabetes by insulin. Only a small propor-
tion of patients have been found regularly to monitor their 
blood glucose levels. Reasons included not understanding its 
importance, not knowing how to do it, or lacking the desire 
to do so. In addition, it was found that some patients did not 
know that they could buy monitoring devices themselves 
and believed that these were only sold to health care 
professionals.22,23 A study by Elliott et al22 revealed hazardous 
practices undertaken by patients in controlling their disease, 
by responding poorly to its complications. For example, the 
authors reported that patients used to drink juice or eat sour 
food to counteract their hyperglycemia. Other practices that 
could be hazardous were not being able to recognize hypo-
glycemia, ignoring and not responding to it once detected, 
or going to sleep.
Health awareness and lifestyle
Ali et al27 in their qualitative study reported that some 
participants did not know how to cook healthy food. Others 
needed a program that helped them lose and maintain 
weight.27 Al-Kaabi et al3 reported that patients with DM could 
not count their calorie intake, and only a small proportion of 
them read food labeling. The majority of patients were also 
unable to distinguish between low and high carbohydrate 
index food items.3 In Saudi Arabia, most women with DM 
were unaware of the importance of diet and exercise to control 
their disease, and they were overweight or obese.4
Health beliefs and their impact on patients’ behavior
Patient adherence to treatment is significantly affected by 
health beliefs. It is postulated that there is a relationship 
between beliefs and behavior.26 Psychologists have studied 
this relationship extensively. The use of sociopsychologi-
cal approaches has revealed that health beliefs impact on 
patients’ medicine-taking behavior.44 Vermeire et al45 have 
noted that patients with DM might deliberately choose not 
to adhere to their medicines as a result of their beliefs. An 
explanation for some of these beliefs, which are specific to 
the Middle Eastern population, will now be discussed.
Religious beliefs
Despite the cultural diversity among the population of Middle 
Eastern countries, Islam is the most practiced religion in the 
region. Since Muslims comprise the dominant portion of 
the Middle Eastern population, medical practices are based 
on Islamic beliefs. Religious beliefs hold that death is part 
of God’s plan. Consequently, ensuring patients appreciate 
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the seriousness and urgency of making lifestyle changes 
and taking appropriate actions is challenging. Patients’ 
management of their diabetes will be influenced by their 
religious beliefs, including “fatalism”. Fatalism refers to 
a belief that “events are controlled and predetermined by 
Allah and that humans have little, if any, control over their 
destinies”. Severe untreated cases of diabetes can lead to 
death, and there are verses of the Holy Quran and prophet’s 
sayings that stress disease prevention and treatment. Despite 
this fact, religious beliefs and strong faith in God’s control 
may discourage patients from engaging in activities that are 
against God’s will.17 In this regard, Jeragh-Alhaddad et al36 
found that many patients believed that only God can cure 
diabetes and not doctors or medicines.
Beliefs about fasting during Ramadan
In Ramadan, when people are obliged to abstain from eating 
and drinking between sunrise and sunset, patients with diabe-
tes change their medicine-taking behavior without consulting 
their doctors.28,46 A study by Salti et al7 revealed that 20% 
of patients using oral antidiabetic medicines and 37% of 
patients using insulin changed their doses during Ramadan. 
Patients reported that they reduced their oral doses because 
they believed that while they were not eating traditional 
foodstuffs, they did not need to take their medicines.7 Lawton 
et al47 reported that some patients believed that taking their 
medicines without eating several large meals would further 
reduce their blood glucose levels and expose them to more 
side effects.
Self-beliefs
Self-efficacy, which refers to patients’ beliefs in their ability 
to change and succeed, has been described in two studies. In 
one study, it was noted that self-efficacy was significantly 
associated with patients’ adherence to treatment recom-
mendations. Patients who had lower self-efficacy showed 
higher resistance to treatment recommendations and 
consequently lower adherence to oral medications.28 Patients 
who perceived that they had control over their condition and 
medicines better adhered to their therapeutic regimens.37 
On the other hand, beliefs in the efficacy of self-care prac-
tices, such as undertaking sufficient levels of physical activity 
and controlling dietary intake, encouraged patients not to 
adhere to medicines.19
Beliefs about efficacy and necessity
Jamous et al20 and Alhyas et al26 concluded that beliefs regard-
ing the balance of necessity and efficacy against costs and 
risks were influential. Patients who believed in the necessity 
of taking medicines were more likely to be adherents.23,24,35,29 
On the other hand, patients who perceived medicines to 
be ineffective and those with longer duration of diabetes 
and more complications were least likely to adhere to their 
treatments.13,25,30,37,38 Consequently, low cure beliefs affected 
patients’ health outcomes, such as psychological well-being, 
recovery, survival, and treatment-related behavior (eg, 
adherence).48 Conversely, some studies have described ways 
in which confidence about the efficacy of medicines may 
negatively impact on other aspects of diabetes management. 
For example, patients who believed that T2DM could be 
managed with drugs did not spend time with their health 
care professionals to discuss other important management 
behaviors.26
Belief in the health care provider
A study by Abdulhadi et al31 highlighted some weaknesses 
in the patient–provider interaction from the perspec-
tives of patients. The weaknesses were mainly related to 
the communication skills of the health care providers. 
Patients were hindered from participating in the manage-
ment process, which resulted in their dissatisfaction with 
the services provided. The patients reported some barriers 
to good diabetes management, such as a lack of continu-
ity of care and inexperienced health care providers. The 
study has revealed that patients who continued their care 
with one primary care provider had better adherence to 
appointments and treatments. Consequently, these patients 
achieved glycemic control. Patients preferred to be seen by 
the same doctor because they believed that they would get 
better advice regarding their problems. Moreover, some 
patients perceived that continuity of care with the same 
health care provider was a salient element in building their 
confidence and improving their relationship with doctors.31 
Another study reported that some patients lacked trust in 
the government health care system, turning to the private 
sector to receive better care. In this study, patients reported 
unavailability of medicines, discontinuity of care, doctors’ 
paternalism, and inequalities of services provided as barriers 
to better management of diabetes.36 Aflakseir37 concluded that 
a weak relationship between doctor and patient was associ-
ated with medication non adherence. Patients’ lack of belief 
in the competence of doctors and nurses also significantly 
impacted health outcomes.37 Reduced levels of trust in the 
scientific medical knowledge of health care professionals 
other than specialists led to poor adherence to appointments 
and oral antidiabetic medication.26,31,39
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Lifestyle and diabetes
Physical activity
Several social environmental barriers have been identified 
as contributing to low physical activity levels. For example, 
households in the Middle East (especially Saudi Arabia, 
Qatar, and Kuwait) have a common practice of employing 
maids, which reduces physical activity expended for domes-
tic chores.39 This was highlighted in a qualitative study, 
where participants attributed their increased weight to their 
dependence on housemaids.27 Patients with T2DM in Kuwait 
identified lack of time, coexisting diseases, extreme weather 
conditions, the abundance of maids, and excessive use of cars 
as barriers to engagement in recommended levels of physical 
activity.40 Badran and Laher32 noted that after marriage, 
couples become less active and consume more food during 
cultural joint meals. Also, it has been claimed that cultural 
barriers restrict women’s access to outdoor activities; the 
availability of culturally acceptable exercise facilities is 
limited and expensive.2,27 There are also some traditional 
cultural expectations that couples will have a high number 
of children, which means high fertility rates in women and 
short periods between pregnancies. This may further limit 
their opportunities for physical activity and increases their 
chances of obesity.2
Dietary habits
Dietary habits have undergone dramatic changes in the last 
30 years, with low dietary fiber and high-fat intake leading to 
obesity and DM in the Middle East.32 Serour et al40 reported 
barriers to following a healthy diet. These include lack of 
desire, stress, type of traditional food, difficulty in adhering 
to a diet that is different from other family members, and 
the high frequency of social gatherings.40 In addition, in 
Arab-speaking countries, the social processes of gatherings 
require consumption of mainly meat, fat, rice, and carbohy-
drates.32 Hospitality and generosity are important Islamic 
values, whereby individuals wish to serve and encourage 
guests to consume large amounts of food as a sign of 
friendliness and demonstration of honor. Guests may find 
it difficult to refuse food, which might be interpreted as a 
sign of illness or low ingratitude.27,49 Additionally, in some 
Middle Eastern countries, especially the Gulf Cooperation 
Council countries, people strongly believe in the nutritional 
and economic value of dates. Consequently, they consume 
dates frequently with coffee during the day as part of their 
culture. Consumption of large quantities of dates may affect 
glycemic control of patients with DM due to their high 
sugar content.26,31,33
Discussion
The findings of this review indicate that the problem of 
nonadherence to treatment is prevalent among patients with 
T2DM in the Middle East. This review has investigated the 
determinants of such patients’ behavior in order to propose 
services and recommendations targeted at those determi-
nants. This should help in counteracting such behavior and 
lead to improved health outcomes in the region. The review 
revealed that lack of health awareness, health beliefs, and 
culture have a significant influence on patients’ adherence 
to treatment and lifestyle measures. Different methodolo-
gies were employed to obtain the results of the reviewed 
studies. Most studies used questionnaires to collect data, 
whereas few studies applied interviews and focus groups. 
All the reviewed studies were conducted with adult patients 
with DM (predominantly T2DM). One study was conducted 
with participants at high risk of T2DM and two studies were 
conducted with health care professionals.
Lack of health awareness is common among patients with 
DM in the Middle East. It has been found that patients lacked 
an awareness of the seriousness of diabetes.12,14,16,22–24,35,36,43 
In addition, this poor awareness was associated with different 
practices, such as the use of herbs instead of conventional 
treatment, and stopping or taking less medication to avoid 
adverse effects.17,26,36 Also, lack of health awareness of the role 
of diet and exercise led to difficulties in weight management 
and obesity.3,4,27 Some specific beliefs of the Middle Eastern 
population were also identified in this review. Examples of 
these beliefs are religious beliefs in God’s control and in the 
“evil eye”, beliefs about fasting in Ramadan, self-belief, and 
beliefs about necessity of treatment and in health care provid-
ers. From the studies that discussed these beliefs, it was con-
spicuous how these beliefs impacted patients’ behavior and 
the management of diabetes.7,13,18,19,23–25,29,31,35,39,47–49,50 Cultural 
factors that were found to influence patients’ behavior were 
also identified. It was found that culture impacted adherence 
to lifestyle measures, such as diet and physical activity, and 
led to high obesity rates in the region and consequent poor 
health outcomes.2,32,39,40,48
Enhancing educational efforts by health care profession-
als to improve patients’ health awareness, modify health 
beliefs, and address sociocultural factors should play a 
major role in improving patients’ behavior. Improving 
patients’ medicine use and other management responsibili-
ties will improve the management of T2DM in the region 
and also improve health outcomes. In addition, enhancing 
patients’ trust in the quality of the health care services 
is important. This could be achieved by implementing 
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strategies for assessing and improving the quality of the 
health care services provided.24,26,51 Also, at the govern-
mental level, reinforcing and strengthening strategies for 
prevention and early diagnosis of T2DM should be taken 
into consideration.
Limitations of the review
Identification of papers was through electronic databases and 
handsearching. All of the reviewed studies were published 
in English. A limitation of this review was related to the 
heterogeneity of the reviewed studies. The studies were 
carried out on different populations (although they were 
mostly from Eastern Mediterranean countries) from various 
levels of health care provision and used different methodolo-
gies and adherence measurements and follow-up duration. 
In addition, the studies reported variable outcome measures, 
eg, some studies covered both T1DM and T2DM, whereas 
others focused on T2DM only. Due to a lack of published 
studies, this review did not include data from all Middle 
Eastern countries. Therefore, the outcomes of the review are 
of a broad nature, and their relevance to population groups in 
other countries, societies, and contexts is unclear. However, 
the strengths of the review were that it incorporated data 
related to the wider management of diabetes in the region 
and did not only focus on adherence studies. In addition, 
data provided here could be considered adequate to comment 
on the potential implications for T2DM care in the Middle 
Eastern region.
Practice implications
The increased prevalence of T2DM and the poor glycemic 
control among the Eastern Mediterranean population calls for 
further research, particularly to identify the determinants of 
patients’ behavior. For better management of this disease, a 
collaborative approach between patients, their families, health 
care professionals, and the government should be adopted. The 
health awareness of patients, which is a determinant of their 
behavior, should be improved by increasing education efforts. 
This could be achieved by modifying physician–patient com-
munication to accommodate health beliefs and culture.
In a study by Alhyas et al,26 it was found that beliefs and 
attitudes of some health care professionals might constitute 
an obstacle to the management of DM in the Middle East. 
For example, some health care professionals were poorly 
motivated to get involved in patients’ care. This was due to 
beliefs that diabetes is a complex disease, needs intensive 
care, and the complications are hard to control once they have 
occurred. Some health care professionals perceived the poor 
compliance of patients to treatment plans and not achieving 
target goals as barriers to their motivation and contribution 
to the management process. Also, this reduced their motiva-
tion to the provision of high-quality diabetes care. Therefore, 
stressing the need for continuous education and training for 
health care professionals and applying a system for credit and 
qualifications would enhance their responsibility in providing 
better disease management.
The lack of a multidisciplinary approach in patients’ 
care has been reported in several studies. Four studies have 
concluded that health care professionals, such as dietitians, 
chiropodists, ophthalmologists, or health educators, did not 
see patients following their diagnosis.3,31,34,42 Another study by 
Biderman et al39 reported that physicians are the health care 
providers most involved in diabetes care in all health sectors. 
However, doctors usually concentrate on the disease rather 
than the whole person and neglect the importance of patient 
perceptions and satisfaction. Patient dissatisfaction is a major 
factor contributing to medicine misuse and nonadherence.11 
Competent professionals must cooperate in order to provide 
patients with the required skills for maintaining untraditional 
desired behavior. Therefore, implementing behavioral strate-
gies, psychological interventions, and services that incorpo-
rate all health care professionals would have a great influence 
on patients’ behavior and health outcomes. Individualization 
of care, taking into consideration the patient, and the societal, 
cultural, and economic variables would also be paramount. 
This would help patients to initiate and maintain behavioral 
change, particularly in lifestyle aspects.50
Conclusion
Prevention and management of T2DM is a priority for 
governments and people in Middle Eastern countries. This 
review identifies a lack of health knowledge about diabetes 
among Middle Eastern populations. The lack of awareness 
impacts on health behaviors and medication adherence and 
has implications for treatment outcomes. Many health beliefs 
and social, cultural, and lifestyle factors that are specific to 
people in Middle Eastern countries have been identified. 
These have been found to be important for disease patterns at 
a population level, management strategies at a governmental 
and health professional level, and health behaviors at the indi-
vidual level. Knowledge, beliefs, and cultural and lifestyle 
factors play an important role in patients’ decisions regarding 
medication adherence and lifestyle interventions.
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